Franklin Resources’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$110M Buy
327,124
+51,001
+18% +$16.1M 0.02% 438
2026
Q1
$89M Sell
276,123
-79,951
-22% -$24.7M 0.02% 465
2025
Q4
$105M Buy
356,074
+41,917
+13% +$7.81M 0.03% 422
2025
Q3
$16.7M Buy
314,157
+7
+0% +$339 ﹤0.01% 1003
2025
Q2
$13.2M Buy
314,150
+23
+0% +$876 ﹤0.01% 1046
2025
Q1
$11.9M Sell
314,127
-75,708
-19% -$4.73M ﹤0.01% 1057
2024
Q4
$30M Sell
389,835
-55,398
-12% -$4.01M 0.01% 786
2024
Q3
$31.2M Buy
445,233
+205,335
+86% +$11.1M 0.01% 741
2024
Q2
$9.92M Buy
239,898
+94,603
+65% +$4.47M ﹤0.01% 1080
2024
Q1
$8.87M Buy
+145,295
New +$6.52M ﹤0.01% 1129
2022
Q2
Sell
-18,321
Closed -$2.81M 2438
2022
Q1
$2.81M Hold
18,321
﹤0.01% 1315
2021
Q4
$5.41M Buy
18,321
+1
+0% +$293 ﹤0.01% 1204
2021
Q3
$5.08M Hold
18,320
﹤0.01% 1198
2021
Q2
$5.02M Buy
18,320
+1,653
+10% +$592K ﹤0.01% 1135
2021
Q1
$8.19M Hold
16,667
﹤0.01% 1019
2020
Q4
$13.8M Buy
+16,667
New +$9.73M 0.01% 899

Other funds holding PRAX

Franklin Resources's PRAX Position: Q2 2026 in Review

Franklin Resources increased its Praxis Precision Medicines (PRAX) stake by 18% in Q2 2026, buying an estimated $16.1M and bringing the position to 327,124 shares worth $110M. The position accounts for 0.02% of the portfolio, ranked #438.

Franklin Resources first reported a position in PRAX in Q4 2020 and has held it in 16 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Franklin Resources held 327,124 shares of Praxis Precision Medicines worth $110M as of Q2 2026.
  • Franklin Resources bought 51,001 Praxis Precision Medicines shares in Q2 2026, an estimated $16.1M.
  • Praxis Precision Medicines made up 0.02% of Franklin Resources's portfolio in Q2 2026, its #438 holding.
  • Franklin Resources first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 16 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.